Surgical intervention for patients with fibrinopurulent pleural empyema and acute respiratory failure: a case report.

Postgraduate medicine Pub Date : 2025-03-01 Epub Date: 2025-01-05 DOI:10.1080/00325481.2024.2446009
Hang Guo, Wenmao Zhuang, Yan Zhang, Xiao Qi, Baofeng Li, Jingcheng Wang, Chunguang Wang
{"title":"Surgical intervention for patients with fibrinopurulent pleural empyema and acute respiratory failure: a case report.","authors":"Hang Guo, Wenmao Zhuang, Yan Zhang, Xiao Qi, Baofeng Li, Jingcheng Wang, Chunguang Wang","doi":"10.1080/00325481.2024.2446009","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Fibrinopurulent thorax is a rare condition that can lead to respiratory failure. Fibroblastic decortication surgery has been shown to be an effective treatment for chronic empyema in previous studies. However, there is limited evidence supporting surgical intervention for fibrinopurulent thorax in cases of respiratory failure.</p><p><strong>Case description: </strong>We report a case of a male patient with a fibrinopurulent thorax and acute respiratory failure. The patient required invasive mechanical ventilation but showed no improvement, necessitating surgical intervention for empyema drainage. DNA gene sequencing technology was employed to diagnose the infection etiology, which facilitated the adjustment of antibiotics. This approach ultimately led to the patient's improvement and liberation from the ventilator.</p><p><strong>Conclusion: </strong>This case demonstrates the efficacy of surgical treatment for fibrinopurulent thorax with respiratory failure, a scenario not previously documented in literature. Successful treatments for pneumonia and chronic empyema in the context of respiratory failure have provided both inspiration and validation for this approach. The findings of this case highlight the potential of surgical intervention as a new treatment option for clinical practice. However, as this is a single case report, further research is necessary to validate the efficacy and safety of this treatment method.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"126-130"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Postgraduate medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/00325481.2024.2446009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Fibrinopurulent thorax is a rare condition that can lead to respiratory failure. Fibroblastic decortication surgery has been shown to be an effective treatment for chronic empyema in previous studies. However, there is limited evidence supporting surgical intervention for fibrinopurulent thorax in cases of respiratory failure.

Case description: We report a case of a male patient with a fibrinopurulent thorax and acute respiratory failure. The patient required invasive mechanical ventilation but showed no improvement, necessitating surgical intervention for empyema drainage. DNA gene sequencing technology was employed to diagnose the infection etiology, which facilitated the adjustment of antibiotics. This approach ultimately led to the patient's improvement and liberation from the ventilator.

Conclusion: This case demonstrates the efficacy of surgical treatment for fibrinopurulent thorax with respiratory failure, a scenario not previously documented in literature. Successful treatments for pneumonia and chronic empyema in the context of respiratory failure have provided both inspiration and validation for this approach. The findings of this case highlight the potential of surgical intervention as a new treatment option for clinical practice. However, as this is a single case report, further research is necessary to validate the efficacy and safety of this treatment method.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
纤维蛋白脓性胸膜脓肿合并急性呼吸衰竭的手术治疗1例。
背景:纤维蛋白脓性胸是一种罕见的可导致呼吸衰竭的疾病。在以往的研究中,纤维母细胞去皮手术已被证明是治疗慢性脓胸的有效方法。然而,有有限的证据支持手术干预纤维蛋白脓性胸呼吸衰竭的情况下。病例描述:我们报告一例男性患者纤维蛋白脓性胸腔和急性呼吸衰竭。患者需要有创机械通气,但没有改善,需要手术干预以引流脓胸。采用DNA基因测序技术诊断感染病因,便于抗生素的调整。这种方法最终使患者的病情得到改善,并从呼吸机中解脱出来。结论:这个病例证明了手术治疗纤维蛋白脓性胸合并呼吸衰竭的有效性,这种情况以前没有文献记载。在呼吸衰竭的情况下,肺炎和慢性脓胸的成功治疗为这种方法提供了灵感和验证。该病例的发现突出了手术干预作为临床实践的新治疗选择的潜力。然而,由于这是一个单一的病例报告,需要进一步的研究来验证这种治疗方法的有效性和安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Impact of low-dose aspirin on the prevalence of anemia in elderly patients: a systematic review and meta-analysis. Surgical intervention for patients with fibrinopurulent pleural empyema and acute respiratory failure: a case report. Trends of primary health care practitioners toward bleeding management in Saudi Arabia: a cross-sectional analysis. Quality of guidelines for hyperthyroidism: systematic quality assessment using the AGREE II tool. A review of venous thromboembolism for the hospitalist.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1